WITH EACH NEW RULING about coverage for a proprietary diagnostic assay, Medicare officials send a message to the entire clinical laboratory industry that any lab company with a proprietary test needs to submit adequate clinical evidence that demonstrates two positive aspects of the test. First, that the assay accurately measures the biomarkers that it says …
California Lab Company Closes After Negative Medicare Decision Read More »
